Intellia Therapeutics has become the first dedicated genome editing company to participate in the 100,000 Genomes Project
New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.
IBM Watson Health and Illumina have announced a new partnership to tackle the interpretation of cancer genome data
This issue of the magazine brings us face to face with some of the key note speakers from Festival of Genomics London 2017
Cancer screening startup GRAIL are looking to raise $1 billion in Series B financing, diluting parent company Illumina’s stake to less than 20%
A lack of concrete timetables has some concerned that the 21st Century Cures Act, now signed into law, could take years to implement
The latest episode of Genentech’s new show (Two Scientists Walk Into A Bar) looks at cell to cell communication, and what goes wrong when disease strikes
Latest results from the PGen Study show how customers respond to common cancer risk information from direct-to-consumer tests